For instance, miR-342-5p reduces cancer cell proliferation by targeting a cell cycle regulator Cyclin D1 (encoded by the CCND1 gene), and is reported to be downregulated in chronic myeloid leukemia patients [46]. Here, CCND1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.